Do analysts prefer ZCMD or HKPD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zhongchao 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, ZCMD or HKPD?

Hong Kong Pharma Digital Technology has higher revenue and earnings than Zhongchao. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zhongchao $11.38M 0.07 -$6.31M N/A N/A Hong Kong Pharma Digital Technology $13.43M 0.33 -$1.14M N/A N/A

Is ZCMD or HKPD more profitable?

Company Net Margins Return on Equity Return on Assets Zhongchao N/A N/A N/A Hong Kong Pharma Digital Technology N/A N/A N/A

Do analysts rate NIVF or ZCMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NewGenIvf Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Zhongchao 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, NIVF or ZCMD?

NewGenIvf Group has higher earnings, but lower revenue than Zhongchao. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NewGenIvf Group $4.73M 0.69 $9.88M N/A N/A Zhongchao $11.38M 0.07 -$6.31M N/A N/A

Is NIVF or ZCMD more profitable?

Company Net Margins Return on Equity Return on Assets NewGenIvf Group N/A N/A N/A Zhongchao N/A N/A N/A

Do analysts prefer ZCMD or RDGT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zhongchao 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, ZCMD or RDGT?

Ridgetech has higher revenue and earnings than Zhongchao. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zhongchao $11.38M 0.07 -$6.31M N/A N/A Ridgetech $132.16M 0.02 -$1.25M N/A N/A

Is ZCMD or RDGT more profitable?

Company Net Margins Return on Equity Return on Assets Zhongchao N/A N/A N/A Ridgetech N/A N/A N/A

Do analysts prefer IVF or ZCMD?

INVO Fertility presently has a consensus price target of $20.00, indicating a potential upside of 1,786.79%. Given INVO Fertility's stronger consensus rating and higher probable upside, equities research analysts plainly believe INVO Fertility is more favorable than Zhongchao. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score INVO Fertility 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Zhongchao 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, IVF or ZCMD?

Zhongchao has higher revenue and earnings than INVO Fertility. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio INVO Fertility $6.84M 0.39 -$25.13M -$33.83 N/A Zhongchao $11.38M 0.07 -$6.31M N/A N/A

Do analysts prefer ZCMD or MNDR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zhongchao 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Mobile-health Network Solutions 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, ZCMD or MNDR?

Mobile-health Network Solutions has lower revenue, but higher earnings than Zhongchao. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zhongchao $11.38M 0.07 -$6.31M N/A N/A Mobile-health Network Solutions $7.65M 0.18 -$3.38M N/A N/A

Is ZCMD or MNDR more profitable?

Company Net Margins Return on Equity Return on Assets Zhongchao N/A N/A N/A Mobile-health Network Solutions N/A N/A N/A

Zhongchao (ZCMD) Competitors

$0.73 -0.20 (-21.84%)

Closing price 04:00 PM Eastern

Extended Trading

$0.72 -0.01 (-0.76%)

As of 05:43 PM Eastern

Compare

ZCMD vs. HKPD, NIVF, RDGT, IVF, and MNDR

Should you buy Zhongchao stock or one of its competitors? Zhongchao's main competitors and comparable companies include Hong Kong Pharma Digital Technology (HKPD), NewGenIvf Group (NIVF), Ridgetech (RDGT), INVO Fertility (IVF), and Mobile-health Network Solutions (MNDR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Zhongchao compare to Hong Kong Pharma Digital Technology?

Zhongchao (NASDAQ:ZCMD) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

Zhongchao has a beta of -0.01, meaning that its stock price is 101% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.33, meaning that its stock price is 133% more volatile than the broader market.

In the previous week, Zhongchao had 1 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 2 mentions for Zhongchao and 1 mentions for Hong Kong Pharma Digital Technology. Zhongchao's average media sentiment score of 0.00 equaled Hong Kong Pharma Digital Technology'saverage media sentiment score.

Company	Overall Sentiment
Zhongchao	Neutral
Hong Kong Pharma Digital Technology	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zhongchao	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Zhongchao	N/A	N/A	N/A
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

1.7% of Zhongchao shares are held by institutional investors. 28.6% of Zhongchao shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Hong Kong Pharma Digital Technology has higher revenue and earnings than Zhongchao.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zhongchao	$11.38M	0.07	-$6.31M	N/A	N/A
Hong Kong Pharma Digital Technology	$13.43M	0.33	-$1.14M	N/A	N/A

Summary

Hong Kong Pharma Digital Technology beats Zhongchao on 4 of the 7 factors compared between the two stocks.

How does Zhongchao compare to NewGenIvf Group?

NewGenIvf Group (NASDAQ:NIVF) and Zhongchao (NASDAQ:ZCMD) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

Company	Net Margins	Return on Equity	Return on Assets
NewGenIvf Group	N/A	N/A	N/A
Zhongchao	N/A	N/A	N/A

NewGenIvf Group has a beta of 0.01, meaning that its stock price is 99% less volatile than the broader market. Comparatively, Zhongchao has a beta of -0.01, meaning that its stock price is 101% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NewGenIvf Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Zhongchao	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

66.2% of NewGenIvf Group shares are owned by institutional investors. Comparatively, 1.7% of Zhongchao shares are owned by institutional investors. 31.8% of NewGenIvf Group shares are owned by insiders. Comparatively, 28.6% of Zhongchao shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

NewGenIvf Group has higher earnings, but lower revenue than Zhongchao.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NewGenIvf Group	$4.73M	0.69	$9.88M	N/A	N/A
Zhongchao	$11.38M	0.07	-$6.31M	N/A	N/A

In the previous week, NewGenIvf Group had 2 more articles in the media than Zhongchao. MarketBeat recorded 4 mentions for NewGenIvf Group and 2 mentions for Zhongchao. Zhongchao's average media sentiment score of 0.00 beat NewGenIvf Group's score of -0.22 indicating that Zhongchao is being referred to more favorably in the news media.

Company	Overall Sentiment
NewGenIvf Group	Neutral
Zhongchao	Neutral

Summary

NewGenIvf Group beats Zhongchao on 6 of the 8 factors compared between the two stocks.

How does Zhongchao compare to Ridgetech?

Zhongchao (NASDAQ:ZCMD) and Ridgetech (NASDAQ:RDGT) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

Zhongchao has a beta of -0.01, suggesting that its stock price is 101% less volatile than the broader market. Comparatively, Ridgetech has a beta of -0.13, suggesting that its stock price is 113% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zhongchao	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Zhongchao	N/A	N/A	N/A
Ridgetech	N/A	N/A	N/A

Ridgetech has higher revenue and earnings than Zhongchao.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zhongchao	$11.38M	0.07	-$6.31M	N/A	N/A
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A

In the previous week, Zhongchao and Zhongchao both had 2 articles in the media. Zhongchao's average media sentiment score of 0.00 equaled Ridgetech'saverage media sentiment score.

Company	Overall Sentiment
Zhongchao	Neutral
Ridgetech	Neutral

1.7% of Zhongchao shares are held by institutional investors. Comparatively, 45.3% of Ridgetech shares are held by institutional investors. 28.6% of Zhongchao shares are held by company insiders. Comparatively, 22.6% of Ridgetech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Zhongchao and Ridgetech tied by winning 3 of the 6 factors compared between the two stocks.

How does Zhongchao compare to INVO Fertility?

INVO Fertility (NASDAQ:IVF) and Zhongchao (NASDAQ:ZCMD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.

In the previous week, INVO Fertility and INVO Fertility both had 2 articles in the media. INVO Fertility's average media sentiment score of 0.00 equaled Zhongchao'saverage media sentiment score.

Company	Overall Sentiment
INVO Fertility	Neutral
Zhongchao	Neutral

INVO Fertility has a beta of 2.32, meaning that its stock price is 132% more volatile than the broader market. Comparatively, Zhongchao has a beta of -0.01, meaning that its stock price is 101% less volatile than the broader market.

Zhongchao has a net margin of 0.00% compared to INVO Fertility's net margin of -116.29%. Zhongchao's return on equity of 0.00% beat INVO Fertility's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-116.29%	-85.54%	-31.05%
Zhongchao	N/A	N/A	N/A

Zhongchao has higher revenue and earnings than INVO Fertility.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.84M	0.39	-$25.13M	-$33.83	N/A
Zhongchao	$11.38M	0.07	-$6.31M	N/A	N/A

12.0% of INVO Fertility shares are owned by institutional investors. Comparatively, 1.7% of Zhongchao shares are owned by institutional investors. 0.4% of INVO Fertility shares are owned by company insiders. Comparatively, 28.6% of Zhongchao shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

INVO Fertility presently has a consensus price target of $20.00, indicating a potential upside of 1,786.79%. Given INVO Fertility's stronger consensus rating and higher probable upside, equities research analysts plainly believe INVO Fertility is more favorable than Zhongchao.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Zhongchao	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

INVO Fertility and Zhongchao tied by winning 6 of the 12 factors compared between the two stocks.

How does Zhongchao compare to Mobile-health Network Solutions?

Zhongchao (NASDAQ:ZCMD) and Mobile-health Network Solutions (NASDAQ:MNDR) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Mobile-health Network Solutions has lower revenue, but higher earnings than Zhongchao.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zhongchao	$11.38M	0.07	-$6.31M	N/A	N/A
Mobile-health Network Solutions	$7.65M	0.18	-$3.38M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zhongchao	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Mobile-health Network Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Zhongchao	N/A	N/A	N/A
Mobile-health Network Solutions	N/A	N/A	N/A

In the previous week, Zhongchao and Zhongchao both had 2 articles in the media. Mobile-health Network Solutions' average media sentiment score of 1.74 beat Zhongchao's score of 0.00 indicating that Mobile-health Network Solutions is being referred to more favorably in the news media.

Company	Overall Sentiment
Zhongchao	Neutral
Mobile-health Network Solutions	Very Positive

Zhongchao has a beta of -0.01, indicating that its share price is 101% less volatile than the broader market. Comparatively, Mobile-health Network Solutions has a beta of -0.82, indicating that its share price is 182% less volatile than the broader market.

1.7% of Zhongchao shares are owned by institutional investors. 28.6% of Zhongchao shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Zhongchao beats Mobile-health Network Solutions on 4 of the 7 factors compared between the two stocks.

Get Zhongchao News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZCMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZCMD vs. The Competition

Export

Metric	Zhongchao	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$844K	$10.00B	$7.31B	$12.78B
Dividend Yield	N/A	2.55%	2.54%	10.79%
P/E Ratio	N/A	34.99	271.78	24.19
Price / Sales	0.07	5.09	696.74	129.13
Price / Cash	N/A	24.64	28.87	36.86
Price / Book	0.00	5.49	11.34	6.52
Net Income	-$6.31M	$312.92M	$3.46B	$347.97M
7 Day Performance	-27.97%	0.59%	3.23%	1.57%
1 Month Performance	-48.04%	1.39%	8.82%	5.24%
1 Year Performance	-99.91%	16.31%	27.70%	17.87%

Zhongchao Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZCMD Zhongchao	0.1743 of 5 stars	$0.73 -21.8%	N/A	-99.9%	$844K	$11.38M	N/A	140	Analyst Upgrade Short Interest Increase
HKPD Hong Kong Pharma Digital Technology	0.5087 of 5 stars	$0.40 -2.3%	N/A	-64.2%	$4.62M	$13.43M	N/A	19	Gap Down
NIVF NewGenIvf Group	2.0114 of 5 stars	$0.55 -9.7%	N/A	-99.8%	$3.47M	$4.73M	N/A	N/A	Short Interest Increase
RDGT Ridgetech	0.6474 of 5 stars	$0.82 +6.5%	N/A	-99.6%	$3.01M	$132.16M	N/A	980	Short Interest Increase
IVF INVO Fertility	1.8534 of 5 stars	$1.43 -6.5%	$20.00 +1,298.6%	-97.7%	$2.23M	$6.84M	N/A	10	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ZCMD) was last updated on 8/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zhongchao (ZCMD) Competitors

ZCMD vs. HKPD, NIVF, RDGT, IVF, and MNDR

How does Zhongchao compare to Hong Kong Pharma Digital Technology?

Summary

How does Zhongchao compare to NewGenIvf Group?

Summary

How does Zhongchao compare to Ridgetech?

Summary

How does Zhongchao compare to INVO Fertility?

Summary

How does Zhongchao compare to Mobile-health Network Solutions?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZCMD vs. The Competition

Zhongchao Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Zhongchao (ZCMD) Competitors

ZCMD vs. HKPD, NIVF, RDGT, IVF, and MNDR

How does Zhongchao compare to Hong Kong Pharma Digital Technology?

Which has more risk and volatility, ZCMD or HKPD?

Does the media refer more to ZCMD or HKPD?

Do analysts prefer ZCMD or HKPD?

Is ZCMD or HKPD more profitable?

Do institutionals & insiders hold more shares of ZCMD or HKPD?

Which has higher valuation & earnings, ZCMD or HKPD?

Summary

How does Zhongchao compare to NewGenIvf Group?

Is NIVF or ZCMD more profitable?

Which has more risk & volatility, NIVF or ZCMD?

Do analysts rate NIVF or ZCMD?

Do institutionals and insiders have more ownership in NIVF or ZCMD?

Which has better valuation & earnings, NIVF or ZCMD?

Does the media refer more to NIVF or ZCMD?

Summary

How does Zhongchao compare to Ridgetech?

Which has more volatility & risk, ZCMD or RDGT?

Do analysts prefer ZCMD or RDGT?

Is ZCMD or RDGT more profitable?

Which has stronger valuation & earnings, ZCMD or RDGT?

Does the media prefer ZCMD or RDGT?

Do insiders & institutionals hold more shares of ZCMD or RDGT?

Summary

How does Zhongchao compare to INVO Fertility?

Does the media favor IVF or ZCMD?

Which has more volatility & risk, IVF or ZCMD?

Is IVF or ZCMD more profitable?

Which has stronger valuation and earnings, IVF or ZCMD?

Do insiders and institutionals believe in IVF or ZCMD?

Do analysts prefer IVF or ZCMD?

Summary

How does Zhongchao compare to Mobile-health Network Solutions?

Which has preferable valuation & earnings, ZCMD or MNDR?

Do analysts prefer ZCMD or MNDR?

Is ZCMD or MNDR more profitable?

Does the media refer more to ZCMD or MNDR?

Which has more volatility & risk, ZCMD or MNDR?

Do institutionals and insiders believe in ZCMD or MNDR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZCMD vs. The Competition

Zhongchao Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools